GO:1902911 protein kinase complex: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1902911 (protein kinase complex) is a cellular component defined as a protein complex capable of protein kinase activity.
• These complexes are central to signal transduction, often organized as cascades such as the AMPK/Snf1 and MAPK pathways.
• Key subunits include catalytic kinases (e.g., AMPKα, MEK) and regulatory/scaffold proteins (e.g., KSR, Npr1) that control substrate specificity and localization.
• Dysregulation of protein kinase complexes is implicated in cancer, metabolic disorders, and autophagy defects.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable precise interrogation of complex assembly and function.
• EDITGENE provides end-to-end services for generating and screening protein kinase complex models, from KO to library screening and bioinformatics.
Description
Protein kinase complexes (GO:1902911) are macromolecular assemblies that catalyze protein phosphorylation, a fundamental post-translational modification controlling nearly all cellular processes. These complexes are not merely catalytic dimers; they often comprise catalytic subunits, regulatory subunits, and scaffold proteins that dictate substrate specificity, subcellular localization, and signal integration. For example, the AMP-activated protein kinase (AMPK) complex exists as a heterotrimer of α, β, and γ subunits, with the α subunit providing kinase activity and the β/γ subunits regulating nucleotide binding and substrate recruitment. Similarly, the MAPK cascade relies on scaffold proteins such as KSR to assemble RAF, MEK, and ERK into functional signaling modules. Understanding the composition, assembly, and regulation of these complexes is essential for dissecting signaling networks and developing targeted therapeutics. This article provides a comprehensive overview of GO:1902911, integrating structural, functional, and disease-related insights from authoritative literature.
protein kinase complex At A Glance
| GO ID | GO:1902911 |
|---|---|
| GO term | protein kinase complex |
| Ontology | cellular_component |
| Synonym | none |
| Major function | Catalysis of protein phosphorylation; signal transduction; regulation of cellular processes |
| Examples | AMPK/Snf1 complex, MAPK cascade complexes, TORC1-regulated Npr1 complex, ULK1-TBK1 complex |
| Subunits | Catalytic kinase subunits, regulatory subunits, scaffold proteins |
| Localization | Cytoplasm, nucleus, Golgi, mitochondria, and other compartments |
| Disease relevance | Cancer, metabolic disorders, neurodegeneration, autophagy-related diseases |
What Is GO:1902911?
According to the Gene Ontology, GO:1902911 (protein kinase complex) is a cellular component defined as a protein complex which is capable of protein kinase activity. This means the complex as a whole can transfer a phosphate group from ATP to a protein substrate, typically on serine, threonine, or tyrosine residues. The term encompasses both homomeric and heteromeric complexes, including those with regulatory and scaffold subunits that modulate the kinase activity.
Why Is protein kinase complex Important in Cell Biology?
Protein kinase complexes are pivotal in cellular signaling, acting as molecular switches that integrate environmental cues and orchestrate responses such as growth, metabolism, and stress adaptation. Their dysfunction is linked to a wide range of human diseases, making them prime targets for drug discovery. Moreover, understanding their assembly and regulation provides mechanistic insights into fundamental biology and enables the development of precision therapeutics.
• Central to signal transduction cascades, including AMPK, MAPK, and mTOR pathways.
• Regulate key cellular processes: metabolism, autophagy, cell cycle, and apoptosis.
• Mutations or dysregulation contribute to cancer, diabetes, and neurodegenerative diseases.
• Serve as drug targets; e.g., trametinib inhibits MEK within KSR-bound complexes.
• Scaffold proteins like KSR and Npr1 determine signaling specificity and subcellular localization.
• Involved in selective autophagy through ULK1-TBK1 complexes.
• Provide a framework for understanding allosteric regulation and substrate selection.
• Enable high-throughput screening for kinase inhibitors and genetic modifiers.
• Essential for cellular responses to stress, nutrients, and growth factors.
• Offer opportunities for CRISPR-based functional genomics and drug discovery.
What Happens During protein kinase complex?
Assembly and Activation
In simple terms: The complex is built from multiple protein subunits that come together and switch on.
Protein kinase complexes assemble from catalytic and regulatory subunits in response to specific signals. For instance, AMPK is activated by AMP binding to the γ subunit, which promotes phosphorylation of the α subunit by upstream kinases. Similarly, the ULK1 complex is activated during autophagy initiation through phosphorylation by TBK1 and interactions with NDP52. Scaffold proteins such as KSR facilitate the assembly of RAF-MEK-ERK modules, ensuring efficient signal transmission.
Substrate Recognition and Phosphorylation
In simple terms: Once active, the complex finds target proteins and adds phosphate tags to them.
The catalytic subunit of the complex recognizes specific substrate motifs and transfers a phosphate group from ATP to serine, threonine, or tyrosine residues. Regulatory subunits and scaffolds often enhance substrate specificity by positioning the kinase near its targets. For example, the Npr1 kinase within TORC1-regulated complexes phosphorylates Orm proteins to stimulate sphingolipid synthesis.
Signal Integration and Feedback
In simple terms: The complex integrates multiple signals and can shut itself off through feedback loops.
Protein kinase complexes often receive inputs from multiple upstream pathways and are subject to feedback inhibition. AMPK activity is modulated by cellular energy status and can be inhibited by phosphatases. In the MAPK cascade, scaffold proteins prevent cross-talk and ensure fidelity, while negative feedback phosphorylation of upstream components dampens signaling.
Localization and Dynamics
In simple terms: The complex moves to specific parts of the cell where it is needed.
Subcellular localization of protein kinase complexes is tightly controlled. Protein Kinase D2 assembles a multiprotein complex at the trans-Golgi network to regulate matrix metalloproteinase secretion. Similarly, ULK1 complexes localize to autophagosomes, and AMPK shuttles between cytoplasm and nucleus depending on energy stress.
Key Genes Involved in GO:1902911 protein kinase complex
The following genes encode core components and regulators of protein kinase complexes, as supported by the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PRKAA1 | Catalytic α1 subunit of AMPK | Energy sensing, metabolic regulation |
| PRKAA2 | Catalytic α2 subunit of AMPK | Metabolic control, autophagy |
| PRKAB1 | Regulatory β1 subunit of AMPK | Scaffolding, substrate targeting |
| PRKAG1 | Regulatory γ1 subunit of AMPK | AMP/ATP binding, allosteric activation |
| SNF1 | Yeast homolog of AMPKα | Model for AMPK signaling |
| ULK1 | Autophagy-initiating kinase | Selective autophagy, TBK1-NDP52 axis |
| TBK1 | Kinase that activates ULK1 | Autophagy, innate immunity |
| NDP52 | Autophagy receptor | Selective autophagy, ULK1 activation |
| MAP3K8 | RAF family kinase | MAPK cascade, cancer |
| MAP2K1 | MEK1, MAPK kinase | Drug target, trametinib |
| KSR1 | Scaffold for RAF-MEK-ERK | MAPK specificity, cancer |
| NPR1 | Yeast kinase in TORC1 pathway | Sphingolipid synthesis, nutrient signaling |
| ORM1 | Substrate of Npr1 | Sphingolipid regulation |
| PRKD2 | Protein Kinase D2 | Golgi function, MMP secretion |
| MMP2 | Matrix metalloproteinase | Secretory pathway, cancer |
| PRKACA | cAMP-dependent protein kinase catalytic subunit | Broad signaling, metabolism |
| PRKAR1A | Regulatory subunit of PKA | Signal integration, disease |
How Is protein kinase complex Regulated?
Protein kinase complexes are regulated at multiple levels: post-translational modifications (e.g., phosphorylation, ubiquitination), allosteric activation by second messengers (e.g., AMP, cAMP), and interaction with regulatory subunits or scaffolds. For example, AMPK is allosterically activated by AMP and phosphorylated by LKB1 or CaMKKβ. The TORC1 pathway regulates Npr1 to control sphingolipid synthesis in yeast. In the MAPK cascade, scaffold proteins like KSR modulate signal duration and specificity. Additionally, subcellular localization and feedback phosphorylation provide spatiotemporal control.
protein kinase complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MAP2K1 | Melanoma, colorectal cancer | Point mutation (e.g., V600E) knock-in in cell lines |
| KSR1 | Cancer, MAPK signaling | Knockout and overexpression models |
| PRKAA1 | Type 2 diabetes, metabolic syndrome | Knockout and point mutation (e.g., T172D) |
| ULK1 | Neurodegeneration, autophagy defects | Knockout and tagged knock-in for localization |
| PRKD2 | Cancer metastasis, Golgi dysfunction | Overexpression and knockout in secretory cells |
Cancer
Dysregulation of protein kinase complexes is a hallmark of cancer. Mutations in MAPK pathway components, such as MEK and KSR, drive tumorigenesis, and the complex is targeted by drugs like trametinib. AMPK complexes play dual roles in cancer, acting as metabolic checkpoints and influencing cell survival under stress.
Metabolic Disorders
AMPK complexes are central to energy homeostasis; their dysfunction is linked to type 2 diabetes and obesity. Mutations in AMPK subunits can cause metabolic syndromes, and the complex is a target for antidiabetic drugs.
Neurodegeneration
Autophagy-related kinase complexes, including ULK1 and TBK1, are implicated in neurodegenerative diseases such as amyotrophic lateral sclerosis and Parkinson's disease, where impaired clearance of protein aggregates contributes to pathology.
Secretory and Golgi-related Diseases
Protein Kinase D2 complexes at the trans-Golgi network regulate matrix metalloproteinase secretion; their dysregulation may contribute to cancer invasion and metastasis.
From protein kinase complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of AMPKα affect energy stress response? | PRKAA1/2 double knockout cell lines |
| How does MEK mutation alter drug sensitivity? | MAP2K1 point mutation knock-in (e.g., V600E) |
| Where does ULK1 localize during autophagy? | ULK1 tagged knock-in (e.g., GFP) |
| Can KSR1 overexpression drive MAPK hyperactivation? | KSR1 overexpression stable cell line |
| What is the role of Npr1 in sphingolipid synthesis? | NPR1 knockout yeast models |
| Does PRKD2 regulate MMP secretion? | PRKD2 knockout and overexpression in HeLa cells |
How to Study the protein kinase complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| AP-MS | Protein-protein interactions, complex composition | Identifying novel subunits of AMPK or MAPK complexes |
| In vitro kinase assay | Catalytic activity, substrate phosphorylation | Testing inhibitors or mutations in MEK |
| Live-cell imaging | Subcellular localization, dynamics | Tracking ULK1 during autophagy |
| CRISPR knockout screening | Gene essentiality, pathway dependencies | Identifying modifiers of drug response |
| Phosphoproteomics | Global phosphorylation changes | Mapping substrates of AMPK or Npr1 |
| Co-immunoprecipitation | Physical interactions | Validating scaffold-kinase binding |
| FRET biosensors | Kinase activity in live cells | Monitoring AMPK or PKA activity |
Proteomic Analysis of Complex Composition
Affinity purification coupled with mass spectrometry (AP-MS) can identify subunits and interactors of protein kinase complexes. For example, KSR-bound MEK complexes were characterized using structural and biochemical approaches. This method reveals dynamic assembly and post-translational modifications.
Kinase Activity Assays
In vitro kinase assays using recombinant subunits or immunoprecipitated complexes measure catalytic activity and substrate specificity. AMPK activity is often assessed by phosphorylation of synthetic peptides or known substrates like ACC.
Live-cell Imaging
Fluorescence microscopy of tagged subunits (e.g., GFP-ULK1) allows real-time tracking of complex localization and dynamics during processes like autophagy. This is crucial for understanding spatiotemporal regulation.
Genetic Screens and CRISPR Libraries
CRISPR knockout libraries can systematically identify genes required for complex function or drug sensitivity. For instance, screens targeting MAPK components have revealed resistance mechanisms.
How CRISPR Can Be Used to Study GO:1902911 protein kinase complex
Knockout
CRISPR knockout of catalytic or regulatory subunits (e.g., PRKAA1, KSR1) abolishes complex function, enabling loss-of-function studies. For example, ULK1 knockout impairs autophagy, and AMPK knockout alters metabolic responses.
Point Mutation
Introducing specific point mutations (e.g., kinase-dead or activation-loop mutations) via CRISPR base editing or HDR allows precise dissection of catalytic activity and regulation. MEK mutations like V600E are modeled to study drug resistance.
Knock-in
Tagged knock-in (e.g., GFP, HA) of endogenous subunits enables real-time imaging and proteomic analysis without overexpression artifacts. ULK1-GFP knock-in has been used to track autophagosome formation.
Overexpression
CRISPR activation (CRISPRa) or stable overexpression of wild-type or mutant subunits can amplify signaling and reveal gain-of-function phenotypes. Overexpression of KSR1 enhances MAPK pathway output.
How EDITGENE Supports protein kinase complex Research
Researchers studying protein kinase complex-related genes often need to determine whether a candidate gene is causally involved in complex assembly, signaling, or disease. EDITGENE provides a comprehensive suite of CRISPR services to generate precisely engineered cell models, enabling functional validation and drug discovery.
Contact EDITGENE today to design your custom CRISPR model for protein kinase complex research.
Frequently Asked Questions About protein kinase complex
What is GO:1902911?
GO:1902911 is a Gene Ontology term for protein kinase complex, a cellular component defined as a protein complex capable of protein kinase activity.
What genes are involved in protein kinase complex?
Key genes include PRKAA1, PRKAA2, ULK1, TBK1, MAP2K1, KSR1, NPR1, and PRKD2, among others.
What is the function of protein kinase complex?
It catalyzes protein phosphorylation, thereby regulating signal transduction, metabolism, autophagy, and many other cellular processes.
How is protein kinase complex regulated?
Regulation occurs via allosteric activation, post-translational modifications, scaffold proteins, and subcellular localization.
What diseases are associated with protein kinase complex dysfunction?
Cancer, metabolic disorders, neurodegeneration, and secretory diseases are linked to dysregulated kinase complexes.
What methods are used to study protein kinase complexes?
Common methods include AP-MS, in vitro kinase assays, live-cell imaging, CRISPR screening, and phosphoproteomics.
Can CRISPR be used to study protein kinase complexes?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable precise functional dissection.
What is the role of AMPK complex in metabolism?
AMPK senses energy status and regulates glucose and lipid metabolism; its dysfunction is linked to diabetes.
How does the MAPK complex transmit signals?
Scaffold proteins like KSR assemble RAF, MEK, and ERK to ensure efficient and specific signal transduction.
What services does EDITGENE offer for kinase complex research?
EDITGENE provides knockout, point mutation, knock-in, overexpression cell models, CRISPR library screening, and bioinformatics support.
Conclusion
Protein kinase complexes (GO:1902911) are fundamental signaling machines that orchestrate diverse cellular functions through phosphorylation. Their precise composition, regulation, and localization are critical for normal physiology, and their dysregulation underlies numerous diseases. Advances in CRISPR-based models and high-throughput screening are accelerating our understanding of these complexes and enabling the development of targeted therapies. EDITGENE stands ready to support researchers with tailored services to explore every aspect of protein kinase complex biology.
References
- 1. Sanz P et al.. 2016. AMPK in Yeast: The SNF1 (Sucrose Non-fermenting 1) Protein Kinase Complex.. Exp Suppl 107:353-374 PMID: 27812987
- 2. Vargas JNS et al.. 2019. Spatiotemporal Control of ULK1 Activation by NDP52 and TBK1 during Selective Autophagy.. Mol Cell 74(2):347-362.e6 PMID: 30853401
- 3. Khan ZM et al.. 2020. Structural basis for the action of the drug trametinib at KSR-bound MEK.. Nature 588(7838):509-514 PMID: 32927473
- 4. Eiseler T et al.. 2016. Protein Kinase D2 Assembles a Multiprotein Complex at the Trans-Golgi Network to Regulate Matrix Metalloproteinase Secretion.. J Biol Chem 291(1):462-77 PMID: 26507660
- 5. Sanz P. 2008. AMP-activated protein kinase: structure and regulation.. Curr Protein Pept Sci 9(5):478-92 PMID: 18855699
- 6. Hardie DG et al.. 1992. AMP-activated protein kinase--an archetypal protein kinase cascade?. Bioessays 14(10):699-704 PMID: 1365882
- 7. Shimobayashi M et al.. 2013. TORC1-regulated protein kinase Npr1 phosphorylates Orm to stimulate complex sphingolipid synthesis.. Mol Biol Cell 24(6):870-81 PMID: 23363605
- 8. Brown MD et al.. 2009. Protein scaffolds in MAP kinase signalling.. Cell Signal 21(4):462-9 PMID: 19091303
